UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
August 3, 2022 4:30 P.M.
Form:
S-1
CIK:
0000810509
Company Name:
NAVIDEA BIOPHARMACEUTICALS, INC.
File Number:
333-262691